Literature DB >> 7561773

Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups.

H Tokita1, H Okamoto, P Luengrojanakul, K Vareesangthip, T Chainuvati, H Iizuka, F Tsuda, Y Miyakawa, M Mayumi.   

Abstract

Nine (10%) out of 90 hepatitis C virus (HCV) isolates from hepatitis patients and commercial blood donors in Thailand were not classifiable into any of genotypes I/1a, II/1b, III/2a, IV/2b, V/3a or VI/3b by RT-PCR with type-specific primers deduced from the HCV core gene. These isolates were sequenced over a 1.6 kb stretch of the 5'-terminal sequence and 1.1 kb of the 3'-terminal sequence covering 30% of the entire genome. Based on two-by-two comparison and phylogenetic analyses of the nine Thailand isolates among themselves and with known full or partial sequences of previously reported HCV isolates, the Thailand isolates were classified into five genotypes not reported previously, viz. 6b, 7c, 7d, 9b and 9c. Along with HCV isolates reported already, they make at least nine major genetic groups of HCV which further break down into at least 28 genotypes with sequence similarity in the E1 gene (576 bp) of < or = 80%. As many more HCV isolates of distinct genotypes are expected to be found throughout the world, it will become increasingly difficult to classify them by comparison of any partial sequences of the genome. Complete sequence data will be required for the full characterization and classification of HCV genotypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561773     DOI: 10.1099/0022-1317-76-9-2329

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Primer sequence modification enhances hepatitis C virus genotype coverage.

Authors:  Yi-Wei Tang; Susan E Sefers; Haijing Li
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Correlation Study Between HCV Genotypes Distribution Pattern and Viral Load in a Tertiary Care Hospital in Kolkata, India.

Authors:  Debojyoti Bhattacharjee; Kheya Mukherjee; Goutam Chakroborti; Ranadeep Ghosh; Nabarun Mandal; Mohua Bose
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 4.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France.

Authors:  Jean-François Cantaloube; Pierre Gallian; Houssam Attoui; Philippe Biagini; Philippe De Micco; Xavier de Lamballerie
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  A serotyping assay for hepatitis C virus in Southeast Asia.

Authors:  S Songsivilai; D Kanistanon; T Dharakul
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.

Authors:  Dale M Netski; Xiao-Hong Wang; Shruti H Mehta; Kenrad Nelson; David Celentano; Satawat Thongsawat; Niwat Maneekarn; Vinai Suriyanon; Jaroon Jittiwutikorn; David L Thomas; John R Ticehurst
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon.

Authors:  Ziyad Mahfoud; Kassem Kassak; Khalil Kreidieh; Sarah Shamra; Sami Ramia
Journal:  Virol J       Date:  2010-05-13       Impact factor: 4.099

9.  Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan.

Authors:  Amjad Ali; Habib Ahmed; Muhammad Idrees
Journal:  Virol J       Date:  2010-08-26       Impact factor: 4.099

10.  HCV genotyping using statistical classification approach.

Authors:  Ping Qiu; Xiao-Yan Cai; Wei Ding; Qing Zhang; Ellie D Norris; Jonathan R Greene
Journal:  J Biomed Sci       Date:  2009-07-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.